Abstract Body

Background

Although life expectancy has improved and AIDS has declined, people with HIV (PWH) now develop more non-AIDS comorbidities. Health-related quality of life for PWH is now primarily influenced by those non-AIDS comorbidities rather than AIDS-defining conditions. We therefore propose a model of HIV disease progression which extends previous models via the inclusion of non-AIDS comorbidities that accumulate across the lifespan.

Methods

This sample included 22,920 demographically matched Military Health System beneficiaries with and without HIV ages 18-64 followed 2003-2018. This healthcare system provided universal access to care, minimizing system-level confounding and isolating patient-level effects. Health states were defined as stages of HIV and the most common non-AIDS comorbidity categories among PWH using 3-character International Classification of Diseases codes (Figure 1A). The 1st and 2nd stage were distinguished by antiretroviral therapy initiation. Health state preferences were derived using SF- 36 data. Markov state transition models simulated the probabilities of being in each state as people aged. Blinder–Oaxaca analyses decomposed differences in survival between people with and without HIV into differences in comorbidity frequency and differences in comorbidity effect on survival.

Results

The sample was mostly male (82%) and similar to the US PWH population (77%). PWH had higher morbidity than people without HIV, predominantly driven by non-AIDS comorbidities. Mental health conditions constituted 3 of the 10 most commonly occurring comorbidity categories among PWH, joint and back conditions 2 of the 10, followed by lipid, hypertensive, renal, respiratory, and diabetic disorders. Despite improved HIV treatment regimens, life expectancy for PWH continued to lag behind that of people without HIV by 7 years. A large share of this gap was not explained by the differences in morbidity frequency. Given the time spent in each state, traditional HIV disease progression models overestimated quality of life for PWH by 7 quality-adjusted life-years.

Conclusions

Traditional HIV disease progression models anachronistically emphasize AIDS, overlooking the growing burden of non-AIDS comorbidities on health-related quality of life. Blinder–Oaxaca decomposition analyses indicated the higher mortality among PWH, despite the rarity of AIDS, may be largely attributable to this. Non-AIDS comorbidities must therefore be accounted for accurate clinical and economic valuation of treatment for PWH.

Table or Figure